Company profile
InfuSystem Holdings, Inc.
AMEX: INFU · Healthcare · Medical - Instruments & Supplies
#316 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
80B+FH 84DQ 83GM 68SS 74
v0.1 · 65/100 weight · provisional
↑ Piotroski F, growth stability · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$142.4M
Rev growth YoY (TTM)
+3.5%
Net income (FY)
$6.6M
Employees
467
as of 2026-08-13
Market cap
$247.0M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$143.4M$143.4M2025
Net income$6.6M$6.6M2025
Operating income$11.9M$11.9M2025
Total assets$100.6M$100.6M2025
Liabilities$43.2M$43.2M2025
Equity$57.3M$57.3M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Patient Services57%
Device Solutions43%
By geography
Not disclosed.
The read
What is InfuSystem Holdings, Inc.’s revenue?
InfuSystem Holdings, Inc. booked $143.4M in FY2025 revenue, growing 6.4% year over year — about the middle of the pack among Healthcare companies we track, at a 4.6% net margin.
Peers · Healthcare
Cronos Group Inc.69BKaryopharm Therapeutics Inc.49DiAnthus Capital Holdings, Inc.46DBeam Therapeutics Inc.62CSpok Holdings, Inc.83B+Quanterix Corporation56CNeighbors
Oakland →Key facts
CEOCarrie A. Lachance
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersRochester Hills, MI
ExchangeAMEX: INFU
Employees467
IPO date2007-12-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.